A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

NCT06501911 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI leaving institution.

Conditions

Recurrent Glioblastoma
Recurrent High-grade Glioma

Interventions

DRUG: Bicalutamide
RADIATION: Intensity-modulated radiation therapy (IMRT)

Sponsor

University of Nebraska